Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-21 10:21 am Sale |
2024-05-20 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 0 0.000% |
-6,090,980 (Position Closed) |
Filing History |
| 2024-04-29 6:08 pm Purchase |
2024-04-25 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 6,090,980 9.300% |
8,079 (+0.13%) |
Filing History |
| 2024-03-06 12:40 pm Purchase |
2024-03-04 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,862,478 7.800% |
21,052 (+0.24%) |
Filing History |
| 2023-11-22 10:25 am Purchase |
2023-11-20 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 6,082,901 9.800% |
2,918,793 (+92.25%) |
Filing History |
| 2023-10-26 4:11 pm Purchase |
2023-10-24 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,841,426 9.400% |
96,108 (+1.10%) |
Filing History |
| 2022-08-09 3:11 pm Purchase |
2022-08-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,745,318 14.600% |
263,411 (+3.11%) |
Filing History |
| 2022-02-15 2:18 pm Sale |
2022-02-11 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 3,164,108 10.800% |
-13,734 (-0.43%) |
Filing History |
| 2022-01-28 1:39 pm Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Frazier Life Sciences VIII L.P. | 1,264,861 8.400% |
1,062,058 (+523.69%) |
Filing History |
| 2021-09-21 3:37 pm Purchase |
2021-09-17 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 3,177,842 10.000% |
440,741 (+16.10%) |
Filing History |
| 2021-05-12 5:27 pm Sale |
2021-05-10 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 8,481,907 16.900% |
-2,084,883 (-19.73%) |
Filing History |
| 2021-05-04 12:31 pm Purchase |
2021-04-05 | 13D | Aptinyx Inc. APTX |
Frazier Life Sciences VIII L.P. | 3,195,055 4.800% |
4,976 (+0.16%) |
Filing History |
| 2021-02-09 11:14 am Purchase |
2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 10,566,790 21.700% |
24,000 (+0.23%) |
Filing History |
| 2021-02-04 4:37 pm Sale |
2020-11-12 | 13D | Aptinyx Inc. APTX |
Frazier Life Sciences VIII L.P. | 3,190,079 5.100% |
-50,037 (-1.54%) |
Filing History |
| 2020-10-06 2:42 pm Unchanged |
2020-10-06 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
Frazier Life Sciences VIII L.P. | 10,542,790 24.100% |
0 (Unchanged) |
Filing History |
| 2020-07-30 8:16 pm Purchase |
2020-07-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 2,737,101 11.500% |
11,475 (+0.42%) |
Filing History |
| 2020-06-18 12:30 pm Sale |
2020-06-11 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Frazier Life Sciences VIII L.P. | 799,953 2.900% |
-250,000 (-23.81%) |
Filing History |
| 2020-04-29 4:46 pm Purchase |
2020-03-03 | 13D | Sierra Oncology, Inc. SRRA |
Frazier Life Sciences VIII L.P. | 202,803 2.000% |
202,803 (New Position) |
Filing History |